<?xml version="1.0"?>
<PC-AssayDescription
    xmlns="http://www.ncbi.nlm.nih.gov"
    xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
    xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
>
  <PC-AssayDescription_aid>
    <PC-ID>
      <PC-ID_id>608182</PC-ID_id>
      <PC-ID_version>2</PC-ID_version>
    </PC-ID>
  </PC-AssayDescription_aid>
  <PC-AssayDescription_aid-source>
    <PC-Source>
      <PC-Source_db>
        <PC-DBTracking>
          <PC-DBTracking_name>ChEMBL</PC-DBTracking_name>
          <PC-DBTracking_source-id>
            <Object-id>
              <Object-id_str>758193</Object-id_str>
            </Object-id>
          </PC-DBTracking_source-id>
        </PC-DBTracking>
      </PC-Source_db>
    </PC-Source>
  </PC-AssayDescription_aid-source>
  <PC-AssayDescription_name>Increase in p53 phosphorylation in human NTUB1 cells after 24 hrs by Western blot analysis</PC-AssayDescription_name>
  <PC-AssayDescription_description>
    <PC-AssayDescription_description_E>Title: 18A?-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.</PC-AssayDescription_description_E>
    <PC-AssayDescription_description_E></PC-AssayDescription_description_E>
    <PC-AssayDescription_description_E>Abstract: Twenty six 18A?-glycyrrhetinic acid (GA) (1) derivatives 2-27 including twelve new GA derivatives 10, 11, 13-17, 21-25 were synthesized and evaluated for cytotoxicities against NTUB1 cells (human bladder cancer cell lines). seco-Compounds 9, 25, and 27 are the most potent compounds of this series, inhibiting cell growth of human NTUB1 cells with an IC(50) values of 2.34 A+/- 0.28, 4.76 A+/- 1.15, and 3.31 A+/- 0.61 A inverted question markM, respectively. Exposure of NTUB1 to 25 for 24h significantly increased the production of reactive oxygen species (ROS). Flow cytometric analysis exhibited that treatment of NTUB1 with 25 did not induce cell cycle arrest but accompanied by an increase of apoptotic cell death in a dose-dependant manner after 24h. Mitochondrial membrane potential (MMP) decreased significantly in a dose-dependant manner when the NTUB1 cells were exposed to 25 for 24h. Marked collapse of the MMP suggested that dysfunction of the mitochondria may be involved in the oxidative burst and apoptosis induced by 25. Western blot analysis shows that NTUB1 cells treated with 25 increased the level of p-p53 in a dose-dependant manner. Further, NAC treatment prevented p53 phosphorylation stimulated by 25. These results suggested that 25 induced a mitochondrial-mediated apoptosis in NTUB1 cells through activation of p53, which are mainly mediated ROS generated by 25.</PC-AssayDescription_description_E>
  </PC-AssayDescription_description>
  <PC-AssayDescription_comment>
    <PC-AssayDescription_comment_E>Journal: Bioorg. Med. Chem.</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Year: 2011</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Volume: 19</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Issue: 14</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>First Page: 4274</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Last Page: 4285</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>DOI: 10.1016/j.bmc.2011.05.054</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E></PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Target ChEMBL ID: CHEMBL4096</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>ChEMBL Target Name: Cellular tumor antigen p53</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Relationship Type: D - Direct protein target assigned</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Confidence: Direct single protein target assigned</PC-AssayDescription_comment_E>
  </PC-AssayDescription_comment>
  <PC-AssayDescription_xref>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_taxonomy>9606</PC-XRefData_taxonomy>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
      <PC-AnnotatedXRef_comment>Homo sapiens</PC-AnnotatedXRef_comment>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_pmid>21696969</PC-XRefData_pmid>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
      <PC-AnnotatedXRef_type value="pcit">1</PC-AnnotatedXRef_type>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_dburl>http://www.ebi.ac.uk/chembldb/</PC-XRefData_dburl>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_asurl>http://www.ebi.ac.uk/chembldb/index.php/assay/inspect/758193</PC-XRefData_asurl>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_protein-gi>269849759</PC-XRefData_protein-gi>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
  </PC-AssayDescription_xref>
  <PC-AssayDescription_results>
    <PC-ResultType>
      <PC-ResultType_tid>1</PC-ResultType_tid>
      <PC-ResultType_name>Standard Type</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Standardized activity type (e.g. IC50 rather than Ic-50/Ic50/ic50/ic-50)</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="string">4</PC-ResultType_type>
    </PC-ResultType>
    <PC-ResultType>
      <PC-ResultType_tid>2</PC-ResultType_tid>
      <PC-ResultType_name>Activity Comment</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Additional comments</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="string">4</PC-ResultType_type>
    </PC-ResultType>
  </PC-AssayDescription_results>
  <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
  <PC-AssayDescription_target>
    <PC-AssayTargetInfo>
      <PC-AssayTargetInfo_name>Cellular tumor antigen p53</PC-AssayTargetInfo_name>
      <PC-AssayTargetInfo_mol-id>269849759</PC-AssayTargetInfo_mol-id>
      <PC-AssayTargetInfo_molecule-type value="protein">1</PC-AssayTargetInfo_molecule-type>
      <PC-AssayTargetInfo_organism>
        <BioSource>
          <BioSource_org>
            <Org-ref>
              <Org-ref_db>
                <Dbtag>
                  <Dbtag_db>taxon</Dbtag_db>
                  <Dbtag_tag>
                    <Object-id>
                      <Object-id_id>9606</Object-id_id>
                    </Object-id>
                  </Dbtag_tag>
                </Dbtag>
              </Org-ref_db>
              <Org-ref_orgname>
                <OrgName>
                  <OrgName_name>
                    <OrgName_name_binomial>
                      <BinomialOrgName>
                        <BinomialOrgName_genus>Homo sapiens</BinomialOrgName_genus>
                      </BinomialOrgName>
                    </OrgName_name_binomial>
                  </OrgName_name>
                </OrgName>
              </Org-ref_orgname>
            </Org-ref>
          </BioSource_org>
        </BioSource>
      </PC-AssayTargetInfo_organism>
      <PC-AssayTargetInfo_descr>Cellular tumor antigen p53</PC-AssayTargetInfo_descr>
      <PC-AssayTargetInfo_comment>
        <PC-AssayTargetInfo_comment_E>Protein Accession: P04637</PC-AssayTargetInfo_comment_E>
      </PC-AssayTargetInfo_comment>
    </PC-AssayTargetInfo>
  </PC-AssayDescription_target>
  <PC-AssayDescription_project-category value="literature-extracted">7</PC-AssayDescription_project-category>
  <PC-AssayDescription_assay-group>
    <PC-AssayDescription_assay-group_E>PMID: 21696969</PC-AssayDescription_assay-group_E>
  </PC-AssayDescription_assay-group>
</PC-AssayDescription>
